These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3252078)

  • 1. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 2. Aztreonam.
    Outman WR
    Conn Med; 1987 Sep; 51(9):611-3. PubMed ID: 3311617
    [No Abstract]   [Full Text] [Related]  

  • 3. Aztreonam: a narrow spectrum against gram-negative aerobes.
    Drug Ther Bull; 1987 Nov; 25(22):86-8. PubMed ID: 3315541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
    Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
    Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
    Sander J
    Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
    [No Abstract]   [Full Text] [Related]  

  • 7. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam: an appraisal.
    Neu HC
    N J Med; 1986 Jan; Spec No():42-5. PubMed ID: 3485269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Criteria for the selection of antibiotics in the empirical therapy of gram negative infections].
    Betts RF
    Internist (Berl); 1981 Nov; 22(11):710-4. PubMed ID: 7031008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence and antibiotic-sensitivity of gram-negative bacteria in the urinary infections (author's transl)].
    Lechi A; Arosio E; Pancera P; Montesi G; Mengoli C; Biscardo G; Bonomi U
    Quad Sclavo Diagn; 1980 Sep; 16(3):282-7. PubMed ID: 7244101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aztreonam in infections caused by gram-negative aerobic bacilli].
    Rodríguez French A; Kenion G; Rodríguez C
    Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of aztreonam on the fecal aerobic flora in children].
    Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J
    Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aztreonam: correlation between disk diffusion and agar plate dilutions susceptibility tests.
    Toma EC; Morisset R; Phaneuf D; Poisson M
    Chemotherapy; 1985; 31(6):451-5. PubMed ID: 4075858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
    Tirone F; Musca G; Filomia D; Vigna L
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aztreonam: early clinical studies in New Jersey.
    Johnson ES; Eng RK; Perez EM; Smith LG
    N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
    Sánchez C; Garau J
    Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():67-75. PubMed ID: 2490491
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of non-fermentative gram-negative bacteria in infections. Bacteriological and clinical aspects].
    Turcu T; Liscă M
    Rev Med Chir Soc Med Nat Iasi; 1981; 85(2):275-82. PubMed ID: 7051218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.